3-(4-Chloroquinazolin-2-yl)phenyl acetate, 98%, 100g

2-(chloromethyl)-5-(2-thienyl)-1,3,4-oxadiazole, 95.0%, 250mg

6-Bromo-1H-benzoimidazole-4-carboxylic acid, 95.0%, 100mg

Methyl 3-Bromothiophene-2-carboxylate>98.0%(GC)1g

Dihexyl Fumarate, 25g

2-(2-Chloropyrimidin-4-yl)-1-(4-fluorophenyl)ethan-1-one, 98%, 100mg

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-Nepsilon-tetradecanoyl-L-lysine>98.0%(HPLC)(N)1g

(S)-Methyl 6-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-aminohexanoate hydrochloride, 97%, 250mg

2-Bromo-4-hydroxybenzoic acid, 97%, 5g

(R)-1-(2,6-Dichlorophenyl)ethanamine hydrochloride, 95.0%, 100mg

(R)-1-(Naphthalen-2-yl)propan-1-amine hydrochloride, 95.0%, 250mg

(S)-2-Benzyl 1-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate, 95.0%, 500g

ROTI®NC, Transfermembran, Bogen, Nitrocellulose, 10 x 10 cm, Porengröße 0,2 µm